{'text': 'AstraZeneca shutting asthma drug plant as pipeline shifts to biologics - BioPharma', 'publisher': {'href': 'https://www.biopharma-reporter.com', 'title': 'BioPharma-Reporter.com'}, 'created_at': 'Fri, 12 Dec 2014 08:00:00 GMT', 'description': 'AstraZeneca shutting asthma drug plant as pipeline shifts to biologics  BioPharma-Reporter.com', 'url': 'https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWGxnNWRZYml5WVNwTF81NmVGSVNoX3FfazNrXzMyWHMzZXJBYTNsSGJNWnRTWGhVV3FYakJ1WHhSNGFHVVpWYVU3Q3BNYWhQczhNME5sRGxiQzQ0OEIxTFN0cUw4M3MtR2U0VlhlaUpzNjVqZUVUR1I2MXJUaEJuMGhhZVVBaU5ZMG0zbnNlbjVWRmE3XzF2b2gzTnFXX2wzaGFRLTZrRzJpUlJYbzhUYXo4RHhHZG5hLWFzSlRLNDVDZw?oc=5&hl=en-US&gl=US&ceid=US:en'}
